Quick Answer
Galera Therapeutics, Inc. reported Common Stock Shares Outstanding of 75.46 million shares for the year ending 2025.
- Galera Therapeutics, Inc. showed an increase of +0.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Galera Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Galera Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 25,004.2%.
- Historical annual values: Fiscal year 2025: 75.46 million shares | Fiscal year 2024: 75.46 million shares | Fiscal year 2023: 54.39 million shares | Fiscal year 2022: 28.51 million shares | Fiscal year 2021: 26.46 million shares | Fiscal year 2020: 24.98 million shares | Fiscal year 2019: 24.81 million shares | Fiscal year 2018: 300,597 shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: